Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001790340-25-000135
Filing Date
2025-11-12
Accepted
2025-11-12 16:19:17
Documents
70
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q imrx-20250930.htm   iXBRL 10-Q 1647397
2 EX-10.1 imrx-20250930xex101.htm EX-10.1 38651
3 EX-31.1 imrx-20250930xex311.htm EX-31.1 10103
4 EX-31.2 imrx-20250930xex312.htm EX-31.2 10218
5 EX-32.1 imrx-20250930xex321.htm EX-32.1 5051
6 EX-32.2 imrx-20250930xex322.htm EX-32.2 5187
  Complete submission text file 0001790340-25-000135.txt   6656207

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imrx-20250930.xsd EX-101.SCH 39688
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imrx-20250930_cal.xml EX-101.CAL 54491
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imrx-20250930_def.xml EX-101.DEF 273157
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imrx-20250930_lab.xml EX-101.LAB 541026
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imrx-20250930_pre.xml EX-101.PRE 426503
72 EXTRACTED XBRL INSTANCE DOCUMENT imrx-20250930_htm.xml XML 649952
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Filer) CIK: 0001790340 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40675 | Film No.: 251473070
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)